![]() |
|
#1
|
|||
|
|||
|
ZURICH (Reuters) - Swiss biotech group Actelion Ltd will investigate an all-oral combination therapy for patients with relapsing multiple sclerosis (RMS), it said, calling it the first study of this approach for treating the neurological disorder. ??????? ??????: Actelion to investigate all-oral MS combination therapy || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|